He Yuxian, Zhou Yusen, Wu Hao, Kou Zhihua, Liu Shuwen, Jiang Shibo
Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10021, USA.
J Clin Microbiol. 2004 Nov;42(11):5309-14. doi: 10.1128/JCM.42.11.5309-5314.2004.
Antigenic sites on the nucleocapsid (N) protein of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) were mapped by Pepscan analysis with overlapping peptides that span the N protein sequence. Two major immunodominant epitopes located in the C-terminal region (amino acids [aa] 362 to 412) and middle region (aa 153 to 178) reacted with more than 75% of sera from SARS patients. Several minor immunodominant epitopes were reactive with about 50% of the SARS sera. Antisera from mice immunized with inactivated SARS-CoV recognized the two major immunodominant epitopes and one antigenic site located adjacent to the N-terminal region (aa 76 to 101), which did not react with the sera from SARS patients. Several monoclonal antibodies against SARS-CoV bound to the N- or C-terminal antigenic sites. These results suggest that the above antigenic sites on the N protein are important in eliciting humoral immune response against SARS-CoV in humans and animals and can be used as antigens for developing diagnostic tests.
通过用跨越核衣壳(N)蛋白序列的重叠肽进行Pepscan分析,绘制了严重急性呼吸综合征(SARS)冠状病毒(SARS-CoV)N蛋白上的抗原位点。位于C末端区域(氨基酸[aa]362至412)和中间区域(aa 153至178)的两个主要免疫显性表位与超过75%的SARS患者血清发生反应。几个次要免疫显性表位与约50%的SARS血清发生反应。用灭活的SARS-CoV免疫的小鼠抗血清识别两个主要免疫显性表位和一个位于N末端区域附近(aa 76至101)的抗原位点,该位点不与SARS患者的血清发生反应。几种抗SARS-CoV单克隆抗体与N或C末端抗原位点结合。这些结果表明,N蛋白上的上述抗原位点在引发人和动物针对SARS-CoV的体液免疫反应中很重要,可作为开发诊断测试的抗原。